DEEP-VEIN THROMBOSIS - PREVALENCE OF ETIOLOGIC FACTORS AND RESULTS OF MANAGEMENT IN 100 CONSECUTIVE PATIENTS

被引：65

作者：

BICK, RL

JAKWAY, J

BAKER, WF

机构：

[1] UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT MED,DIV HEMATOL ONCOL,BAKERSFIELD,CA

[2] UNIV CALIF LOS ANGELES,CTR HLTH SCI,REG CANC & BLOOD DIS CTR KERN,BAKERSFIELD,CA

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1992年 / 18卷 / 02期

关键词：

D O I：

10.1055/s-2007-1002434

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：267 / 274

页数：8

相关论文

共 79 条

[1] ASSAY OF DERMATAN SULFATE COFACTOR (HEPARIN COFACTOR-II) ACTIVITY IN HUMAN-PLASMA
ABILDGAARD, U
LARSEN, ML
[J]. THROMBOSIS RESEARCH, 1984, 35 (03) : 257 - 266
[2] SUBCUTANEOUS ADMINISTRATION OF HEPARIN - A RANDOMIZED COMPARISON WITH INTRAVENOUS ADMINISTRATION OF HEPARIN TO PATIENTS WITH DEEP-VEIN THROMBOSIS
ANDERSSON, G
FAGRELL, B
HOLMGREN, K
JOHNSSON, H
LJUNGBERG, B
NILSSON, E
WILHELMSSON, S
ZETTERQUIST, S
[J]. THROMBOSIS RESEARCH, 1982, 27 (06) : 631 - 639
[3] ANTICARDIOLIPIN ANTIBODIES - CLINICAL ASSOCIATIONS
ASHERSON, RA
HARRIS, EN
[J]. POSTGRADUATE MEDICAL JOURNAL, 1986, 62 (734) : 1081 - 1087
[4] BANEZ EI, 1980, AM J CLIN PATHOL, V74, P569
[5] PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME
BASU, D
CADE, J
GALLUS, A
HIRSH, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) : 324 - +
[6] BENTAL O, 1989, THROMB HAEMOSTASIS, V61, P50
[7] AN OBJECTIVE STUDY OF ALTERNATIVE METHODS OF HEPARIN ADMINISTRATION
BENTLEY, PG
KAKKAR, VV
SCULLY, MF
MACGREGOR, IR
WEBB, P
CHAN, P
JONES, N
[J]. THROMBOSIS RESEARCH, 1980, 18 (1-2) : 177 - 187
[8] BERK PD, 1986, SEMIN HEMATOL, V23, P132
[9] Bick R. L., 1992, DISORDERS THROMBOSIS
[10] CLINICAL RELEVANCE OF ANTI-THROMBIN-III
BICK, RL
[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1982, 8 (04) : 276 - 287

← 1 2 3 4 5 6 7 8 →